Dr. Anna P Andreou completed her PhD in Neurological Sciences and Migraine at the Institute of Neurology-Queen Square, where she investigated the therapeutic potentials of novel pharmacological innervations in migraine treatment. She then moved to the University of California San Francisco, where she focused her research on the investigation of brain networks involved in headache pathophysiology and the effectiveness of neurostimulation in migraine. She is the director of headache research at King's College London and the Headache Centre, where she serves as a consultant headache and pain clinical scientist. Anna's research interests are focused on the neurobiology of headache disorders and the factors influencing the development and evolution of these conditions. Her research focus also extends to the investigation and development of new therapeutic targets for the acute and preventive treatment of migraine of trigeminal autonomic cephalagias and facial pain.
Dr. Guy Carpenter has been studying saliva and salivary glands for 25 years at King’s College London. He is the past president of the Salivary Research Group within the leading association for dental research (IADR) and is still the European president of the Salivary Group for the IADR. His research interests include saliva secretion and function in health and disease with an emphasis on taste and mouthfeel. Mouthfeel involves interactions with foods and drinks and also concernsoral dryness caused by irradiation, medications, or diseases (such as Sjögren's syndrome). In particular, the proteins and the ions that constitute saliva are key to understanding its interactions with the surfaces in the mouth (mucosa and teeth) but also with the microbes that are normally present in the mouth.
Prof. Dr. Bazbek Davletov completed his Ph.D. in the lab of Nobel Prize winner Prof. Thomas Sudhof at the University of Texas Southwestern Medical Center, Dallas, USA. He has been a Program Leader at the MRC Laboratory of Molecular Biology at Cambridge since 1998, before becoming the Chair of Biomedical Science and a Professor at the University of Sheffield. Prof Davletov’s lab pursues research on neurological disorders including chronic neuropathic pain, with a focus on developing enhanced delivery methods. His work encompasses the study of the mechanisms of action of potent neurotoxins and the molecular mechanisms of neurotransmission; based on this research, his group is able to test and utilize potential therapeutic molecules, for example, SNAP25 and botulinum toxins, for the selective treatment of chronic pain.
